HEMAVANT SCIENCES HOLDINGS LIMITED

Active London

Activities of other holding companies n.e.c.

2 employees website.com
Activities of other holding companies n.e.c.
H

HEMAVANT SCIENCES HOLDINGS LIMITED

Activities of other holding companies n.e.c.

Founded 20 Jan 2021 Active London, United Kingdom 2 employees website.com
Activities of other holding companies n.e.c.

Previous Company Names

PHARMAVANT 7 HOLDINGS LIMITED 20 Jan 2021 — 8 Mar 2022
Accounts Submitted 4 Dec 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 3 Feb 2026 Next due 3 Feb 2027 9 months remaining
Net assets £201K £295K 2024 year on year
Total assets £250K £232K 2024 year on year
Total Liabilities £50K £64K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

7th Floor 50 Broadway London SW1H 0DB United Kingdom

Full company profile for HEMAVANT SCIENCES HOLDINGS LIMITED (13146729), an active company based in London, United Kingdom. Incorporated 20 Jan 2021. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

N/A

Net Assets

£200.53k

Increased by £295.25k (+312%)

Total Liabilities

£49.72k

Decreased by £63.58k (-56%)

Turnover

N/A

Employees

2

Debt Ratio

20%

Decreased by 590 (-97%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Vistra Cosec LimitedCorporate-secretaryUnknownUnknown20 Jan 2021Active

Shareholders

Shareholders (1)

Hemavant Sciences Ltd.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Roivant Sciences Ltd.

Bermuda

Active
Notified 1 Oct 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

HEMAVANT SCIENCES HOLDINGS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Apr 2026OfficersChange to director Ms Emma Carys Price on 1 Apr 2026
31 Mar 2026OfficersChange Corporate Secretary Company With Change Date
3 Feb 2026Confirmation StatementConfirmation statement made on 20 Jan 2026 with no updates
4 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
23 Jan 2025Confirmation StatementConfirmation statement made on 20 Jan 2025 with updates
10 Apr 2026 Officers

Change to director Ms Emma Carys Price on 1 Apr 2026

31 Mar 2026 Officers

Change Corporate Secretary Company With Change Date

3 Feb 2026 Confirmation Statement

Confirmation statement made on 20 Jan 2026 with no updates

4 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

23 Jan 2025 Confirmation Statement

Confirmation statement made on 20 Jan 2025 with updates

Recent Activity

Latest Activity

Change to director Ms Emma Carys Price on 1 Apr 2026

2 weeks ago on 10 Apr 2026

Change Corporate Secretary Company With Change Date

3 weeks ago on 31 Mar 2026

Confirmation statement made on 20 Jan 2026 with no updates

2 months ago on 3 Feb 2026

Annual accounts made up to 31 Mar 2025

4 months ago on 4 Dec 2025

Confirmation statement made on 20 Jan 2025 with updates

1 years ago on 23 Jan 2025